A NEW GENERATION OF IMMUNOTHERAPIES
News & Events
AyuVis awarded $2.1 Million NIH grant to support a first-in-human clinical trial
FORT WORTH, TX, May 15th 2023– AyuVis has received an official Notice of Award for a National Institute of Health (NIH) research grant from the National Heart, Lung, and Blood Institute (NHLBI) that will total $2.1M to fund preparations and the initiation of a first-in-human Phase 1 clinical trial.
EY Announces SUCHISMITA ACHARYA of AYUVIS as an Entrepreneur of The Year® 2023 Southwest Award Finalist.
Fort Worth, April 19th 2023 – Ernst & Young LLP (EY US) today announced that Dr. Suchismita Acharya, PhD, Founder & CEO of AyuVis Research was named an Entrepreneur Of The Year® 2023 Southwest Award finalist. Now in its 37th year, Entrepreneur Of The Year is one of the preeminent competitive business awards for transformative entrepreneurs and leaders of high-growth companies who are building a more equitable, sustainable and prosperous world for all.
